Kim Lauper

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Venues

Annals of the rheumatic diseases

RMD open

Revue medicale suisse

BMJ open

University Hospital of Geneva

University of Geneva (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Geneva Jan 11 2017

Switzerland

Clinical research fellow

Education History

University of Geneva - Aug 10 2018

Switzerland

PHD

Publications

Lykke Skaarup, Elvina Ingrid, Alexandre Sepriano, Elena Nikiphorou, René Drage Østgård, Kim Lauper, Ilona Grosse-Michaelis, Margreet Kloppenburg, Bente Glintborg, David F L Liew, Tue Wenzel Kragstrup
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist". Drug safety (2024)
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, Kim Lauper, Cédric Laedermann, Clémentine Perrier, Ruediger Mueller, Delphine Sophie Courvoisier, Axel Finckh
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA. BMJ open 14 (3) (2024)
Kim Lauper, Axel Finckh, Stéphane Genevay, Charlotte Girard-Guyonvarc'h, Romain Guemara, Michael John Nissen, Michele Iudici
[Rheumatology: what's new in 2023]. Revue medicale suisse 20 (856-7) (2024)
Nils Bürgisser, Denis Mongin, Samia Mehouachi, Clement P Buclin, Romain Guemara, Pauline Darbellay Farhoumand, Olivia Braillard, Kim Lauper, Delphine Sophie Courvoisier
Development and validation of a self-updating gout register from electronic health records data. RMD open 10 (2) (2024)
Benoit Thomas P Gilbert, Denis Mongin, Romain Aymon, Kim Lauper, Cédric Laedermann, Clémentine Perrier, Ruediger Mueller, Delphine Sophie Courvoisier, Axel Finckh
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA. BMJ open 14 (3) (2024)
Kim Lauper, Marc-André Schürch, Cem Gabay
[Rheumatology in crisis : rethinking training and care amidst a growing challenge]. Revue medicale suisse 20 (865) (2024)
Nils Bürgisser, Denis Mongin, Samia Mehouachi, Clement P Buclin, Romain Guemara, Pauline Darbellay Farhoumand, Olivia Braillard, Kim Lauper, Delphine Sophie Courvoisier
Development and validation of a self-updating gout register from electronic health records data. RMD open 10 (2) (2024)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, Axel Finckh, Thomas Hügle, Andrea M Burden
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab. RMD open 9 (4) (2023)
Nils Bürgisser, Clement P Buclin, Kim Lauper, Pauline Darbellay Farhoumand, Thomas Agoritsas
[Management of gout in the inpatient setting]. Revue medicale suisse 19 (847) (2023)
Kim Lauper, Lianne Kearsley-Fleet, James B Galloway, Kath D Watson, null null, Kimme L Hyrich, Mark Lunt
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter? Rheumatology (Oxford, England) (2023)
Edouard Chaix, Kim Lauper
[Rheumatoid arthritis flares]. Revue medicale suisse 19 (818) (2023)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Diederik De Cock, Lene Dreyer, Ori Elkayam, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Güzide Nevsun İnanç, Lianne Kearsley-Fleet, Suleyman Serdar Koca, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ana Rodrigues, Ziga Rotar, Anja Strangfeld, Patrick Verschueren, Rasmus Westermann, Jakub Zavada, Delphine Sophie Courvoisier, Axel Finckh, Kim Lauper
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study). Annals of the rheumatic diseases (2023)
Alessia Alunno, Felice Rivellese, Kim Lauper, Daniel Aletaha, Maya H Buch, Laure Gossec, Peter Mandl, Pedro M Machado, Caroline Ospelt, Anna Moltó, Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano
EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future. RMD open 7 (3) (2022)
Denis Mongin, Kim Lauper, Axel Finckh, Thomas Frisell, Delphine Sophie Courvoisier
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study. Annals of the rheumatic diseases 81 (5) (2022)
George E Fragoulis, Elena Nikiphorou, Mrinalini Dey, Sizheng Steven Zhao, Delphine Sophie Courvoisier, Laurent Arnaud, Fabiola Atzeni, Georg Mn Behrens, Johannes Wj Bijlsma, Peter Böhm, Costas A Constantinou, Silvia Garcia-Diaz, Meliha Crnkic Kapetanovic, Kim Lauper, Mariana S F Luís, Jacques Morel, György Nagy, Eva Poleverino, Jef van Rompay, Marco Sebastiani, Anja Strangfeld, Annette de Thurah, James B Galloway, Kimmie L Hyrich
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases (2022)
Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimmie L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Žiga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B M Landewe, Axel Finckh
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Annals of the rheumatic diseases 81 (6) (2022)
Axel Finckh, Benoît Gilbert, Bridget Hodkinson, Sang-Cheol Bae, Ranjeny Thomas, Kevin D Deane, Deshiré Alpizar-Rodriguez, Kim Lauper
Global epidemiology of rheumatoid arthritis. Nature reviews. Rheumatology 18 (10) (2022)
Kim Lauper, Joanna Kedra, Maarten P T de Wit, Bruno Fautrel, Thomas Frisell, Kimme L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Ziga Rotar, Maria Jose Santos, Tanja Alexandra Stamm, Simon R Stones, Anja Strangfeld, Robert B M Landewe, Axel Finckh, Sytske Anne Bergstra, Delphine Sophie Courvoisier
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology. RMD open 7 (3) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, Kim Lauper, Denis Mongin, Florenzo Iannone, Karel Pavelka, Dan C Nordström, Güzide Nevsun İnanç, Catalin Codreanu, Kimmie L Hyrich, Denis Choquette, Anja Strangfeld, Burkhard F Leeb, Ziga Rotar, Ana Rodrigues, Eirik Klami Kristianslund, Tore K Kvien, Ori Elkayam, Galina Lukina, Sytske Anne Bergstra, Axel Finckh, Delphine Sophie Courvoisier
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries. Annals of the rheumatic diseases (2022)
Kim Lauper, Michele Iudici, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, René Cordtz, Diederik De Cock, Lene Dreyer, Ori Elkayam, Ellen-Margrethe Hauge, Doreen Huschek, Kimmie L Hyrich, Florenzo Iannone, Nevsun Inanc, Lianne Kearsley-Fleet, Eirik Klami Kristianslund, Tore K Kvien, Burkhard F Leeb, Galina Lukina, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Anja Strangfeld, Patrick Verschueren, Delphine Sophie Courvoisier, Axel Finckh
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration. Annals of the rheumatic diseases 81 (10) (2022)
Cathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, Tim Cunningham, Romain Guemara, Laure Brulhart, Diana Dan, Delphine Sophie Courvoisier, Axel Finckh
Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab. RMD open 7 (3) (2021)
Kim Lauper, Kimmie L Hyrich
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies. Expert review of clinical immunology (2021)
Benoit Thomas P Gilbert, Céline Lamacchia, Denis Mongin, Kim Lauper, Eric Trunk, Olivia Studer, Delphine Sophie Courvoisier, Andrea Rubbert-Roth, Diego Kyburz, Burkhard Moeller, Axel Finckh
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. BMJ open 11 (7) (2021)
Marco Lanzillotta, Chiara Crotti, Vital Manuel Da Silva Domingues, Kim Lauper, Gerd R Burmester
Publishing in 2@84. Annals of the rheumatic diseases 80 (1) (2020)
Kim Lauper, Johannes W J Bijlsma, Gerd-Rüdiger R Burmester
Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic. Annals of the rheumatic diseases 80 (1) (2020)
Kim Lauper, Delphine Sophie Courvoisier, Cem Gabay
Response to: 'When binary and continuous responses disagree' by Dr Ouyang. Annals of the rheumatic diseases 79 (4) (2019)
Denis Mongin, Kim Lauper, Carl Turesson, Merete Lund Hetland, Eirik Klami Kristianslund, Tore K Kvien, Maria Jose Santos, Karel Pavelka, Florenzo Iannone, Axel Finckh, Delphine Sophie Courvoisier
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? RMD open 5 (2) (2019)
Kim Lauper, Delphine S Courvoisier, Paola Chevallier, Axel Finckh, Cem Gabay
Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis. Arthritis care & research 70 (12) (2019)
Kim Lauper, Denis Mongin, Florenzo Iannone, Eirik Klami Kristianslund, Tore K Kvien, Dan Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria Jose Santos, Catalin Codreanu, Galina Lukina, Delphine S Courvoisier, Cem Gabay
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. RMD open 4 (2) (2018)

Kim Lauper.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kim Lauper